每年專案
指紋
- 1 類似的個人檔案
過去五年中的合作和熱門研究領域
-
探討魚針草酸透過調控癌幹細胞外泌體達到重朔免疫微環境及克服免疫療法抗性頭頸癌之轉譯研究(1/3)
Wu, A. (PI)
8/1/25 → 7/31/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
開發心肌梗塞後綜合治療診斷系統應用於特定階段的心血管修復和再生-運用心臟保護胜肽(CPPs)提升間質幹細胞外泌體(sEVs)功能性達到更精準的心肌梗塞治療與預防(1/3)
Wu, A. (PI)
8/1/25 → 7/31/26
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
A Translational Investigation of Generating Enhanced Mscs and Secretome Using Mfp-Based Proprietary Culture Methods for Dcli Treatment(3/3)
Wu, A. (PI)
8/1/24 → 7/31/25
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
A Translational Investigation of Generating Enhanced Mscs and Secretome Using Mfp-Based Proprietary Culture Methods for Dcli Treatment(2/3)
Wu, A. (PI)
8/1/23 → 7/31/24
研究計畫: A - 政府部門 › b - 國家科學及技術委員會
-
Pathology-tailored nanotherapy via Galectin-3-targeted and triple-responsive nanoparticles enables multimodal therapy against aortic dissection
Lin, C., Tsai, M. L., Chao, H. Y., Cheng, T. M., Shih, C. M., Wu, A. T. H., Cheng, C. H., Hsiao, C. Y., Lu, H. Y., Shih, C. C. & Mi, F. L., 12月 2026, 於: Journal of Nanobiotechnology. 24, 1, 41.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Bioprospection of Hura crepitans metabolites against oxidative stress and inflammation: An in vitro and in silico exploration
Kuo, Y. C., Lawal, B., Lukman, H. Y., Chen, L. C., Huang, S. L., Chen, Y. F., Fadaka, A. O., Olawale, F., Olasupo, A., Ajenifujah, O. T., Fouad, D., Papadakis, M., Batiha, G. E. S., Sabiu, S., Wu, A. T. H. & Huang, H. S., 2025, 於: International Journal of Medical Sciences. 22, 8, p. 1837-1851 15 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Computer-aided drug discovery of a dual-target inhibitor for ovarian cancer: therapeutic intervention targeting CDK1/TTK signaling pathway and structural insights in the NCI-60
Tang, S. L., Sumitra, M. R., Kuo, Y. C., Hsu, H. L., Ansar, M., Huang, S. L., Lee, S. Y., Wang, H. J., Lawal, B., Wu, A. T. H., Chen, L. C. & Huang, H. S., 7月 2025, 於: Computers in Biology and Medicine. 193, 110445.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
In Silico Identification of ANKRD22 as a Theragnostic Target for Pancreatic Cancer and Fostamatinib's Therapeutic Potential
Huynh, H. T. L. K., Lim, H. G. M., Lee, Y. C. G., Phan, T. V., Vo, T. H., Chen, C. H. & Wu, A. T. H., 2025, 於: International Journal of Medical Sciences. 22, 8, p. 1885-1904 20 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
1 引文 斯高帕斯(Scopus) -
Integrated In Silico and Experimental Validation of Antrocin as a Plant-Derived Multi-Target Therapeutic for BRAF/MEK/PI3K-Driven Colorectal Cancer
Chen, J. S., Enwolo-Chibueze, C. G., Chinyama, H. A., Lai, C. T., Ezeala, I. C., Huang, P. Y., Wu, A. T. H. & Huang, Y. J., 9月 2025, 於: International journal of molecular sciences. 26, 18, 8780.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取
資料集
-
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Huang, C.-Y. F. (Contributor), Sung, P.-L. (Contributor) & Wu, A. T. H. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5099513.v1, https://doi.org/10.6084%2Fm9.figshare.c.5099513.v1
資料集: Dataset
-
Additional file 4 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Wu, A. T. H. (Creator), Yeung, S.-C. J. (Contributor), Wen, K.-C. (Creator), Chou, P.-C. (Contributor), Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor) & Sung, P.-L. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845531.v1, https://doi.org/10.6084%2Fm9.figshare.12845531.v1
資料集: Dataset
-
Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor) & Wen, K.-C. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12845528.v1, https://doi.org/10.6084%2Fm9.figshare.12845528.v1
資料集: Dataset
-
Additional file 1 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Chou, P.-C. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Yeung, S.-C. J. (Contributor) & Lee, M.-H. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845522.v1, https://doi.org/10.6084%2Fm9.figshare.12845522.v1
資料集: Dataset
-
Additional file 2 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Huang, C.-Y. F. (Contributor), Chou, P.-C. (Contributor), Wen, K.-C. (Creator), Lee, M.-H. (Contributor), Lin, J.-H. (Contributor), Sung, P.-L. (Contributor), Yeung, S.-C. J. (Contributor) & Wu, A. T. H. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12845525.v1, https://doi.org/10.6084%2Fm9.figshare.12845525.v1
資料集: Dataset